We are a team of BioMedical Design Fellows based at the University of Copenhagen's Department of Health.
Our mission is driven by our four-month observation of obstetrics and gynaecology at Slagelse hospital, where we were moved by the scale and personal impact of pelvic organ prolapse (POP).
Through our ongoing conversations with women affected by prolapse and clinicians in Europe and North America, we are convinced that women deserve better treatment options, and that we can deliver it.
We are developing a device to treat pelvic organ prolapse, and have prototypes ready for testing.
To hear more about our project, including how to trial our products, please don't hesitate to contact us.
Sylvia Health is a team formed during the Novo Nordisk Foundation BioMedical Design Fellowship. For more information about the team, please see our About page.
Thank you for your interest in supporting Sylvia's mission to revolutionise pelvic organ prolapse treatment—an issue that affects millions of women worldwide. We're dedicated to addressing this significant and underserved problem by developing innovative solutions that have the potential to redefine the landscape of women's health. With current treatments falling short of meeting the needs of women, there's a pressing opportunity for groundbreaking change.
As we drive forward in our pursuit of transforming pelvic organ prolapse care, we recognise the immense potential for positive impact and meaningful returns. We invite investors who share our commitment to wellbeing and empowerment to explore partnership opportunities with us. If you're interested in joining our journey or learning more about how you can contribute to our mission, please don't hesitate to contact us.
Feel free to contact Andrew (andrew@sylviahealth.dk) to start a conversation.
Our device is ergonomically designed to fit the natural shape of the vagina. It is easy to insert and remove, allowing for self-management of pelvic organ prolapse and incontinence symptoms.
Pelvic organ prolapse occurs when one or more of the organs in the female pelvis descend into, or out of, the vagina. This condition not only leads to pain and discomfort but also imposes significant mental and emotional challenges, hindering women's ability to fully engage in work, social activities, and family life.
1 in 12 women experience symptomatic prolapse - over 200 million women worldwide. Due to stigma and underreporting, the actual number is likely even higher, and prolapse incidence is growing. In the US alone it is projected to increase by 46% by 2050.
Despite its widespread prevalence and debilitating effects, prolapse often goes overlooked, and current treatment options frequently fall short. Surgery entails a painful recovery, prolonged lifting restrictions, a high likelihood of requiring additional procedures, and facing lengthy waiting lists. Half of women who use a pessary discontinue within 3-12 months - most often due to expulsion, erosion, discomfort & inefficiency.
Surely more can be done? We agree
Our innovative device provides targeted support to correct vaginal bulging, offering a non-surgical alternative for women who can’t have, don’t want or are waiting for surgery.
This supportive device addresses pessary limitations, providing quality of life and empowerment for users, and clinical and cost effective treatment for healthcare providers.
We're determined to make something that actually works, so our medical grade prototypes are currently undergoing rigourous testing by women with prolapse.
So, does it work? Click below to find out more (it's good news)
We use cookies to analyse website traffic and optimise your website experience. By you accepting our use of cookies, your data will be aggregated with all other user data.